The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE) [PDF]
Michal Steffl,1 Jan Sima,2 Kate Shiells,3 Iva Holmerova3 1Department of Physiology and Biochemistry, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic; 2Department of Sport Management, Faculty of Physical Education and ...
Steffl M, Sima J, Shiells K, Holmerova I
doaj +3 more sources
Muscle weakness in cerebral palsy
Over the last two decades, muscle weakness has been shown to be a major component of cerebral palsy (CP) pathology. Caused by multiple etiologies including variations in the muscle fiber type, pathologic motor unit function, co-contraction of agonists ...
Uri Givon
doaj +1 more source
IntroductionAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) frequently leads to mononeuritis multiplex, which are characterized by distal weakness associated with sensory disturbances.
Joe Nemoto +7 more
doaj +1 more source
Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness [PDF]
Background: Dystroglycanopathies are a clinically and genetically heterogeneous group of disorders that are typically characterised by limb-girdle muscle weakness.
Deconinck, Nicolas +31 more
core +1 more source
Causal influence of muscle weakness on cardiometabolic diseases and osteoporosis
The causal roles of muscle weakness in cardiometabolic diseases and osteoporosis remain elusive. This two-sample Mendelian randomization (MR) study aims to explore the causal roles of muscle weakness in the risk of cardiometabolic diseases and ...
Xiaoqing Mou +5 more
doaj +1 more source
Pathogenesis of muscle weakness in inflammatory myositis
Idiopathic inflammatory myositis (IIM) is a heterogeneous group of autoimmune diseases. These are characterized by muscle weakness and fatigue along with other systemic manifestations, ranging from pulmonary alveolitis to vasculopathic ulcers.
Sai Kumar Dunga +2 more
doaj +1 more source
Permanent muscle weakness in hypokalemic periodic paralysis [PDF]
ObjectiveTo map the phenotypic spectrum in 55 individuals with mutations in CACNA1S known to cause hypokalemic periodic paralysis (HypoPP) using medical history, muscle strength testing, and muscle MRI.MethodsAdults with a mutation in CACNA1S known to ...
Fornander, Freja +9 more
core +1 more source
Background Enzyme replacement therapy (ERT; alglucosidase alfa) has improved the prospects for patients with classic infantile Pompe disease considerably.
J. J. A. van den Dorpel +8 more
doaj +1 more source
The aim of the study was to determine the progression of muscle weakness in long-term diabetes and its relation to the neuropathic condition. Thirty patients were recruited from a cohort of 92 diabetic patients who participated in a study on muscular function 6–8 years earlier.
Christer S. Andreassen +2 more
openaire +1 more source
Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease. [PDF]
IntroductionPrevious examination of whole-body muscle involvement in Pompe disease has been limited to physical examination and/or qualitative magnetic resonance imaging (MRI).
Bashir, Mustafa R +7 more
core +1 more source

